Rashi Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 17-06-2024
- Paid Up Capital ₹ 4.00 M
as on 17-06-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.12 Cr
as on 17-06-2024
- Revenue 1.48%
(FY 2023)
- Profit -22.30%
(FY 2023)
- Ebitda -9.43%
(FY 2023)
- Net Worth 5.59%
(FY 2023)
- Total Assets -13.74%
(FY 2023)
About Rashi Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹2.12 Cr.
Avinash Lodam and Sunita Lodam serve as directors at the Company.
- CIN/LLPIN
U74900PN2009PTC135227
- Company No.
135227
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rashi Biotech Private Limited offer?
Rashi Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Enzymes, Food Enzymes, Lipase, Flavours & Aromatics, Textile, Dyeing & Finishing Chemical, Textile Chemical, Antibiotic Injection, Ceftriaxone Injection, Papain.
Who are the key members and board of directors at Rashi Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunita Lodam  | Director | 08-Aug-2011 | Current |
| Avinash Lodam | Director | 30-Dec-2009 | Current |
Financial Performance of Rashi Biotech.
Rashi Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.48% increase. The company also saw a substantial fall in profitability, with a 22.3% decrease in profit. The company's net worth moved up by a moderate rise of 5.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rashi Biotech?
In 2023, Rashi Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jghomson Pharmaceutical And Dental Solutions Private LimitedActive 15 years 4 monthsAvinash Lodam is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 07 Jul 2023 | ₹1.88 M | Open |
Bank Of India Creation Date: 20 May 2023 | ₹1.76 M | Open |
Bank Of India Creation Date: 26 Aug 2020 | ₹0.61 M | Open |
How Many Employees Work at Rashi Biotech?
Unlock and access historical data on people associated with Rashi Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rashi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rashi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
